Research Paper Volume 12, Issue 19 pp 19740—19755
Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma
The protein-based risk signature is an independent prognostic factor both in the discovery and validation cohort. (A) The univariate analysis shows that the risk signature is significantly associated with OS of HNSCC in the discovery cohort. (B) The multivariate analysis demonstrates the risk signature is an independent prognostic factor in the discovery cohort. (C, D) Similar findings are observed in the validation cohort.